Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Fritsch

Showing results (11-20 of 36) with videos related to

Pageof 4
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et alL L van den Hoogen, R D E Fritsch-Stork, J A G van Roon, et al.
Autoimmunity Reviews|January 26, 2018
Performance of the 2012 Systemic Lupus International Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysisEsther A R Hartman, Annet van Royen-Kerkhof, Johannes W G Jacobs, et al.
Annals of the Rheumatic Diseases|June 10, 2019
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndromeLucas L van den Hoogen, Maarten van der Linden, Linde Meyaard, et al.
Autoimmunity Reviews|August 31, 2015
Delineating the deranged immune system in the antiphospholipid syndromeLucas L van den Hoogen, Joël A G van Roon, Timothy R D J Radstake, et al.
Annals of the Rheumatic Diseases|October 1, 2016
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin useLucas L van den Hoogen, Ruth D E Fritsch-Stork, Marjan A Versnel, et al.
RMD Open|July 19, 2018
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scoresLucas L van den Hoogen, Giovanni Palla, Cornelis P J Bekker, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Expression of ERAP2 and LST1 is increased before start of therapy in rheumatoid arthritis patients with good clinical response to glucocorticoidsRuth D E Fritsch-Stork, Sandra C Silva-Cardoso, Marjan J A Groot Koerkamp, et al.
Journal of Immunology Research|May 19, 2022
Corrigendum to "Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births"S J Kroese, M J H de Hair, M Limper, et al.
Journal of Immunology Research|February 3, 2018
Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm BirthsS J Kroese, M J H de Hair, M Limper, et al.
Journal of Clinical Medicine|August 12, 2023
Response to Immunization against SARS-CoV-2 and Risk of Omicron Infection in Dialysis Patients: A Prospective Cohort StudyJohannes Werzowa, Martina Behanova, Ammon Handisurya, et al.
Pageof 4

Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Arthritis & Rheumatology (Hoboken, N.J.)|January 11, 2016
Low-Density Granulocytes Are Increased in Antiphospholipid Syndrome and Are Associated With Anti-β2 -Glycoprotein I Antibodies: Comment on the Article by Yalavarthi et alL L van den Hoogen, R D E Fritsch-Stork, J A G van Roon, et al.
Autoimmunity Reviews|January 26, 2018
Performance of the 2012 Systemic Lupus International Collaborating Clinics classification criteria versus the 1997 American College of Rheumatology classification criteria in adult and juvenile systemic lupus erythematosus. A systematic review and meta-analysisEsther A R Hartman, Annet van Royen-Kerkhof, Johannes W G Jacobs, et al.
Annals of the Rheumatic Diseases|June 10, 2019
Neutrophil extracellular traps and low-density granulocytes are associated with the interferon signature in systemic lupus erythematosus, but not in antiphospholipid syndromeLucas L van den Hoogen, Maarten van der Linden, Linde Meyaard, et al.
Autoimmunity Reviews|August 31, 2015
Delineating the deranged immune system in the antiphospholipid syndromeLucas L van den Hoogen, Joël A G van Roon, Timothy R D J Radstake, et al.
Annals of the Rheumatic Diseases|October 1, 2016
Monocyte type I interferon signature in antiphospholipid syndrome is related to proinflammatory monocyte subsets, hydroxychloroquine and statin useLucas L van den Hoogen, Ruth D E Fritsch-Stork, Marjan A Versnel, et al.
RMD Open|July 19, 2018
Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scoresLucas L van den Hoogen, Giovanni Palla, Cornelis P J Bekker, et al.
Clinical and Experimental Rheumatology|July 8, 2016
Expression of ERAP2 and LST1 is increased before start of therapy in rheumatoid arthritis patients with good clinical response to glucocorticoidsRuth D E Fritsch-Stork, Sandra C Silva-Cardoso, Marjan J A Groot Koerkamp, et al.
Journal of Immunology Research|May 19, 2022
Corrigendum to "Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm Births"S J Kroese, M J H de Hair, M Limper, et al.
Journal of Immunology Research|February 3, 2018
Hydroxychloroquine Use in Lupus Patients during Pregnancy Is Associated with Longer Pregnancy Duration in Preterm BirthsS J Kroese, M J H de Hair, M Limper, et al.
Journal of Clinical Medicine|August 12, 2023
Response to Immunization against SARS-CoV-2 and Risk of Omicron Infection in Dialysis Patients: A Prospective Cohort StudyJohannes Werzowa, Martina Behanova, Ammon Handisurya, et al.
Pageof 4